- Report
- May 2023
- 160 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- March 2023
- 180 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- February 2023
- 150 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- November 2022
- 54 Pages
Global
- Report
- May 2022
- 61 Pages
Global
- Report
- March 2022
- 61 Pages
Global
- Report
- February 2022
- 47 Pages
Global
- Report
- November 2021
- 43 Pages
Global
- Report
- July 2021
- 35 Pages
Global
- Report
- January 2020
- 39 Pages
Global
From €867EUR$950USD£736GBP
- Report
- February 2024
- 184 Pages
Global
From €4428EUR$4,850USD£3,758GBP
- Report
- May 2024
- 169 Pages
Global
From €2283EUR$2,500USD£1,937GBP
- Report
- January 2024
- 200 Pages
Global
From €4565EUR$5,000USD£3,875GBP
- Report
- April 2023
- 310 Pages
Global
From €3196EUR$3,500USD£2,712GBP
€4565EUR$5,000USD£3,875GBP
- Report
- January 2024
- 160 Pages
Global
From €2283EUR$2,500USD£1,937GBP
- Report
- October 2023
- 156 Pages
Global
From €2283EUR$2,500USD£1,937GBP
- Report
- September 2022
- 110 Pages
Global
From €4109EUR$4,500USD£3,487GBP
- Report
- December 2023
- 139 Pages
Global
From €4063EUR$4,450USD£3,448GBP
From €3196EUR$3,500USD£2,712GBP
- Report
- January 2025
- 85 Pages
India
From €3196EUR$3,500USD£2,712GBP

Regenerative Medicine is a field of biotechnology that focuses on the development of treatments and therapies that can restore or replace damaged or diseased cells, tissues, and organs. It is based on the principles of stem cell biology, tissue engineering, and gene therapy. It has the potential to revolutionize the way diseases are treated, and to improve the quality of life for patients.
Regenerative Medicine is a rapidly growing field, with a wide range of applications. It is being used to treat a variety of conditions, including cardiovascular diseases, neurological disorders, and musculoskeletal injuries. It is also being used to develop treatments for cancer, diabetes, and other chronic diseases.
Some of the companies in the Regenerative Medicine market include Athersys, Inc., Celgene Corporation, Osiris Therapeutics, Inc., Vericel Corporation, and Organogenesis, Inc. Show Less Read more